Comment
doi: 10.1001/archinte.166.1.16.
A call for fairness in formulary decisions
- PMID: 16401806
- DOI: 10.1001/archinte.166.1.16
Item in Clipboard
Comment
A call for fairness in formulary decisions
Arch Intern Med.
.
No abstract available
Comment on
-
Medicare coverage of tumor necrosis factor alpha inhibitors as an influence on physicians' prescribing behavior.Arch Intern Med. 2006 Jan 9;166(1):57-63. doi: 10.1001/archinte.166.1.57. Arch Intern Med. 2006. PMID: 16401811
Similar articles
-
Do drug formulary policies reflect evidence of value?Am J Manag Care. 2006 Jan;12(1):30-6. Am J Manag Care. 2006. PMID: 16402886
-
The case for a value-based formulary: striving for total lowest net cost.Manag Care Interface. 2007 Apr;20(4):42-7. Manag Care Interface. 2007. PMID: 17474330
-
The role of pharmacoeconomic guidelines for formulary approval: the Australian experience.Clin Ther. 1993 Nov-Dec;15(6):1154-76; discussion 1120. Clin Ther. 1993. PMID: 8111812
-
Application of pharmacoeconomics to formulary decision making in managed care organizations.Am J Manag Care. 2002 Feb;8(2):161-9. Am J Manag Care. 2002. PMID: 11858228 Review.
-
Chairman of the Joint Formulary Committee, British National Formulary.Clin Med (Lond). 2009 Aug;9(4):349-52. doi: 10.7861/clinmedicine.9-4-349. Clin Med (Lond). 2009. PMID: 19728509 Free PMC article. Review. No abstract available.
Cited by
-
Aberrant leukocyte telomere length in Birdshot Uveitis.PLoS One. 2017 May 1;12(5):e0176175. doi: 10.1371/journal.pone.0176175. eCollection 2017. PLoS One. 2017. PMID: 28459868 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
